Trials / Completed
CompletedNCT00617175
Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III
ADVANCE III: Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,902 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate a reduction in the number of ventricular therapies (ATP and Shocks) delivered for treating spontaneous arrhythmia episodes with a fast cycle length (CL≤ 320ms) as a consequence of self-termination and better arrhythmia discrimination due to a greater number of R-R intervals necessary to detect ventricular events.
Detailed description
Primary Objective: The primary objective is to demonstrate a 20% reduction of ventricular therapies (ATP and Shocks) delivered for treating spontaneous arrhythmia episodes with a fast cycle length (CL ≤ 320 ms) by choosing a number of 30 out of 40 intervals to detect (NID) compared to a NID of 18 out of 24 in subjects with either Class I or IIA indication for ICD implantation, regardless of cardiac resynchronization capabilities. Secondary Objectives: 1. Evaluate the percent reduction in the number of shocks delivered per subject for treating spontaneous episodes with a fast cycle length (CL ≤ 320 ms) and for spontaneous ventricular episodes. 2. Evaluate the efficacy of ATP in successfully treating spontaneous ventricular episodes (CL: 200ms-320ms) for subjects in primary and secondary prevention in both arms of the study. 3. Evaluate acceleration rate or degeneration into VF of spontaneous episodes (CL of 200ms-320ms) due to ATP therapy in the two study arms. 4. Compare the likelihood of syncopal events associated with spontaneous episodes with a fast cycle length (CL ≤ 320 ms). 5. Describe the economic impact and the quality of life consequences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable Defibrillator | Number of 30 out of 40 intervals to detect (NID)Fast Ventricular Tachycardia |
| DEVICE | Implantable Defibrillator | number of 18 out of 24 intervals to detect (NID)Fast Ventricular Tachycardia |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2011-12-01
- Completion
- 2012-02-01
- First posted
- 2008-02-15
- Last updated
- 2025-07-02
- Results posted
- 2013-02-25
Locations
91 sites across 14 countries: Belgium, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, Portugal, Russia, Saudi Arabia, South Africa, Spain
Source: ClinicalTrials.gov record NCT00617175. Inclusion in this directory is not an endorsement.